Balyasny Asset Management’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.3M | Buy |
143,560
+24,637
| +21% | +$5.31M | 0.04% | 522 |
|
|
2025
Q4 | $24.4M | Buy |
118,923
+115,718
| +3,611% | +$21.8M | 0.03% | 621 |
|
|
2025
Q3 | $503K | Sell |
3,205
-32,799
| -91% | -$5.07M | ﹤0.01% | 2395 |
|
|
2025
Q2 | $6.05M | Sell |
36,004
-763,664
| -95% | -$113M | 0.01% | 1193 |
|
|
2025
Q1 | $110M | Buy |
799,668
+462,216
| +137% | +$58.9M | 0.18% | 113 |
|
|
2024
Q4 | $39.9M | Buy |
+337,452
| New | +$39.4M | 0.06% | 397 |
|
|
2024
Q3 | – | Sell |
-5,742
| Closed | -$565K | – | 2767 |
|
|
2024
Q2 | $565K | Sell |
5,742
-8,171
| -59% | -$833K | ﹤0.01% | 2012 |
|
|
2024
Q1 | $1.56M | Sell |
13,913
-254,907
| -95% | -$27.5M | ﹤0.01% | 1635 |
|
|
2023
Q4 | $27.1M | Sell |
268,820
-223,960
| -45% | -$22.2M | 0.05% | 491 |
|
|
2023
Q3 | $42.8M | Buy |
492,780
+390,145
| +380% | +$35.3M | 0.09% | 311 |
|
|
2023
Q2 | $9.71M | Sell |
102,635
-529,212
| -84% | -$44.7M | 0.02% | 796 |
|
|
2023
Q1 | $47.7M | Sell |
631,847
-317,226
| -33% | -$23.9M | 0.12% | 226 |
|
|
2022
Q4 | $73M | Buy |
949,073
+576,220
| +155% | +$43.8M | 0.2% | 120 |
|
|
2022
Q3 | $24.9M | Sell |
372,853
-438,021
| -54% | -$27.8M | 0.08% | 355 |
|
|
2022
Q2 | $42.4M | Buy |
810,874
+795,286
| +5,102% | +$45.2M | 0.14% | 188 |
|
|
2022
Q1 | $884K | Sell |
15,588
-254,695
| -94% | -$13.6M | ﹤0.01% | 1677 |
|
|
2021
Q4 | $13.9M | Buy |
270,283
+245,597
| +995% | +$12M | 0.05% | 539 |
|
|
2021
Q3 | $1.22M | Sell |
24,686
-198,454
| -89% | -$10.8M | 0.01% | 1276 |
|
|
2021
Q2 | $12.7M | Buy |
223,140
+183,194
| +459% | +$10.7M | 0.06% | 427 |
|
|
2021
Q1 | $2.43M | Buy |
+39,946
| New | +$2.2M | 0.01% | 968 |
|
|
2020
Q4 | – | Sell |
-20,620
| Closed | -$968K | – | 1350 |
|
|
2020
Q3 | $968K | Buy |
20,620
+8,926
| +76% | +$458K | 0.01% | 1001 |
|
|
2020
Q2 | $610K | Buy |
+11,694
| New | +$603K | 0.01% | 909 |
|
|
2019
Q3 | – | Sell |
-47,753
| Closed | -$2.25M | – | 1198 |
|
|
2019
Q2 | $2.25M | Buy |
+47,753
| New | +$2.2M | 0.01% | 844 |
|
|
2019
Q1 | – | Sell |
-7,755
| Closed | -$346K | – | 1412 |
|
|
2018
Q4 | $346K | Buy |
+7,755
| New | +$404K | ﹤0.01% | 1189 |
|
|
2018
Q3 | – | Sell |
-64,961
| Closed | -$3.32M | – | 1692 |
|
|
2018
Q2 | $3.17M | Buy |
64,961
+44,300
| +214% | +$2.51M | 0.01% | 796 |
|
|
2018
Q1 | $1.29M | Sell |
20,661
-12,412
| -38% | -$851K | 0.01% | 1125 |
|
|
2017
Q4 | $2.03M | Buy |
33,073
+28,151
| +572% | +$1.74M | 0.01% | 1136 |
|
|
2017
Q3 | $329K | Sell |
4,922
-862,263
| -99% | -$61M | ﹤0.01% | 1495 |
|
|
2017
Q2 | $67.6M | Buy |
867,185
+609,454
| +236% | +$46M | 0.28% | 83 |
|
|
2017
Q1 | $21M | Buy |
257,731
+207,406
| +412% | +$16.3M | 0.1% | 278 |
|
|
2016
Q4 | $3.62M | Buy |
+50,325
| New | +$3.64M | 0.02% | 776 |
|
|
2016
Q3 | – | Sell |
-3,637
| Closed | -$284K | – | 1019 |
|
|
2016
Q2 | $284K | Sell |
3,637
-539,648
| -99% | -$43M | ﹤0.01% | 937 |
|
|
2016
Q1 | $44.5M | Buy |
543,285
+293,334
| +117% | +$23.9M | 0.26% | 102 |
|
|
2015
Q4 | $22.3M | Buy |
+249,951
| New | +$21.2M | 0.15% | 190 |
|
|
2015
Q3 | – | Sell |
-677,387
| Closed | -$56.7M | – | 1149 |
|
|
2015
Q2 | $56.7M | Sell |
677,387
-168,020
| -20% | -$14.8M | 0.35% | 74 |
|
|
2015
Q1 | $76.3M | Buy |
+845,407
| New | +$72.8M | 0.62% | 21 |
|
|
2013
Q3 | – | Sell |
-64,522
| Closed | -$3.04M | – | 579 |
|
|
2013
Q2 | $3.04M | Buy |
+64,522
| New | +$2.95M | 0.05% | 396 |
|
Other funds holding CAH
VCM
VPM
Balyasny Asset Management's CAH Position: Q1 2026 in Review
Balyasny Asset Management increased its Cardinal Health (CAH) stake by 21% in Q1 2026, buying an estimated $5.31M and bringing the position to 143,560 shares worth $30.3M. The position accounts for 0.04% of the portfolio, ranked #522.
Balyasny Asset Management first reported a position in CAH in Q2 2013 and has held it in 37 quarters since. The position peaked at $110M in Q1 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Balyasny Asset Management held 143,560 shares of Cardinal Health worth $30.3M as of Q1 2026.
- Balyasny Asset Management bought 24,637 Cardinal Health shares in Q1 2026, an estimated $5.31M.
- Cardinal Health made up 0.04% of Balyasny Asset Management's portfolio in Q1 2026, its #522 holding.
- Balyasny Asset Management first reported a position in Cardinal Health in Q2 2013 and has held it in 37 quarters since.
- Balyasny Asset Management's Cardinal Health position peaked at $110M in Q1 2025.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.